Michael Chisamore;
Jeffrey Yachnin;
Ana Carneiro;
Linda Mårtensson;
Ingrid Teige;
Björn Frendeus;
Petra Holmkvist;
Andres McAllister;
Marie Borggren;
Ingrid Karlsson;
Mark Cragg;
Lars Ny;
Zsuzsanna Pápai;
Kristoffer Staahl Rohrberg;
Kirstie Cleary;
Jan Anders Nilsson;
Sean Lim;
Johan E Wallin;
Istvan Lang;
Harriet Walter;
Rikke H Lovendahl Eefsen;
Edvard Abel;
Robert Oldham;
Susanne Gertsson
757 Phase 1/2a clinical trial of BI-1808, a monoclonal antibody to tumor necrosis factor receptor 2 (TNFR2) as single agent and in combination with pembrolizumab
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
757 Phase 1/2a clinical trial of BI-1808, a monoclonal antibody to tumor necrosis factor receptor 2 (TNFR2) as single agent and in combination with pembrolizumab
Contributor:
Michael Chisamore;
Jeffrey Yachnin;
Ana Carneiro;
Linda Mårtensson;
Ingrid Teige;
Björn Frendeus;
Petra Holmkvist;
Andres McAllister;
Marie Borggren;
Ingrid Karlsson;
Mark Cragg;
Lars Ny;
Zsuzsanna Pápai;
Kristoffer Staahl Rohrberg;
Kirstie Cleary;
Jan Anders Nilsson;
Sean Lim;
Johan E Wallin;
Istvan Lang;
Harriet Walter;
Rikke H Lovendahl Eefsen;
Edvard Abel;
Robert Oldham;
Susanne Gertsson